← Back to Clinical Trials
Recruiting NCT07010991

NCT07010991 Effectiveness of Artificial Intelligence Based Educational Approach in Developing Clinical Reasoning Skills

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07010991
Status Recruiting
Phase
Sponsor Medipol University
Condition Student
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-05-14
Primary Completion 2025-08-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AI based clinical problem solving educationTraditional Low Back Pain Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-05-14 with a primary completion date of 2025-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In the context of this study, the 2nd and 3rd grade undergraduate students in Medipol University, Department of Physiotherapy and Rehabilitation, will taken into an education program to increase and assess their theoretical knowledge level, clinical decision-making skills and attitudes towards interactive learning with artificial intelligence by applying the ChatGPT-supported PBL module and the results will be compared with traditional teaching methods.

Eligibility Criteria

Inclusion Criteria: * Being an undergraduate student * Being voluntary to attend to the courses Exclusion Criteria: * Not attending to the sessions on time * Being a 4th grade student who already took and learned the process of clinical problem solving * Want to recruit to study during the study process

Contact & Investigator

Central Contact

Simay AKDEMİR, MSc./Lec.

✉ simay.akdemir@medipol.edu.tr

📞 +905347032126

Principal Investigator

Gülay ARAS BAYRAM, Associate Professor

STUDY DIRECTOR

Medipol University İstanbul

Frequently Asked Questions

Who can join the NCT07010991 clinical trial?

This trial is open to participants of all sexes, studying Student. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07010991 currently recruiting?

Yes, NCT07010991 is actively recruiting participants. Contact the research team at simay.akdemir@medipol.edu.tr for enrollment information.

Where is the NCT07010991 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07010991 clinical trial?

NCT07010991 is sponsored by Medipol University. The principal investigator is Gülay ARAS BAYRAM, Associate Professor at Medipol University İstanbul. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology